BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19332263)

  • 21. Comparison of acute changes in left ventricular volume, systolic and diastolic functions, and intraventricular synchronicity after biventricular and right ventricular pacing for heart failure.
    Yu CM; Lin H; Fung WH; Zhang Q; Kong SL; Sanderson JE
    Am Heart J; 2003 May; 145(5):E18. PubMed ID: 12766742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
    Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed reversal of impaired metabolic vasodilation in patients with end-stage heart failure during long-term circulatory support with a left ventricular assist device.
    Khan T; Levin HR; Oz MC; Katz SD
    J Heart Lung Transplant; 1997 Apr; 16(4):449-53. PubMed ID: 9154956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal function and outcome after continuous flow left ventricular assist device implantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Grimm M; Wolner E; Wieselthaler GM
    Ann Thorac Surg; 2009 Apr; 87(4):1072-8. PubMed ID: 19324130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation.
    Puwanant S; Hamilton KK; Klodell CT; Hill JA; Schofield RS; Cleeton TS; Pauly DF; Aranda JM
    J Heart Lung Transplant; 2008 Oct; 27(10):1102-7. PubMed ID: 18926401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiology of the native heart and Thermo Cardiosystems left ventricular assist device complex at rest and during exercise: implications for chronic support.
    Branch KR; Dembitsky WP; Peterson KL; Adamson R; Gordon JB; Smith SC; Jaski BE
    J Heart Lung Transplant; 1994; 13(4):641-50; discussion 651. PubMed ID: 7947881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.
    Vatta M; Stetson SJ; Jimenez S; Entman ML; Noon GP; Bowles NE; Towbin JA; Torre-Amione G
    J Am Coll Cardiol; 2004 Mar; 43(5):811-7. PubMed ID: 14998622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.
    Russell SD; Rogers JG; Milano CA; Dyke DB; Pagani FD; Aranda JM; Klodell CT; Boyle AJ; John R; Chen L; Massey HT; Farrar DJ; Conte JV;
    Circulation; 2009 Dec; 120(23):2352-7. PubMed ID: 19933938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
    Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
    Demirozu ZT; Arat N; Kucukaksu DS
    Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of left ventricular assist device support: Effects on abnormal calcium cycling and functional recovery in the failing human heart.
    Ogletree ML; Sweet WE; Talerico C; Klecka ME; Young JB; Smedira NG; Starling RC; Moravec CS
    J Heart Lung Transplant; 2010 May; 29(5):554-61. PubMed ID: 20044278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation.
    Piacentino V; Troupes CD; Ganapathi AM; Blue LJ; Mackensen GB; Swaminathan M; Felker GM; Stafford-Smith M; Lodge AJ; Rogers JG; Milano CA
    Ann Thorac Surg; 2011 Oct; 92(4):1414-8; discussion 1418-9. PubMed ID: 21958790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
    Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
    J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading.
    Garcia S; Kandar F; Boyle A; Colvin-Adams M; Lliao K; Joyce L; John R
    J Heart Lung Transplant; 2008 Mar; 27(3):261-7. PubMed ID: 18342746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
    J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.